Kathmandu, May 27
Rohto Mentholatum Nepal Pvt Ltd has initiated construction of its upcoming manufacturing facility in Bardibas, Mahottari district, marking a major step in the company’s expansion in Nepal.
The ceremony for the new factory was held on May 14 in Bardibas, Madhes Province, in the presence of the company’s Managing Director, Tran Dang Bich Thao and senior officials of the company.
According to the company, the new facility aims to strengthen its manufacturing presence in Nepal and support its long-term vision for sustainable growth. The factory is expected to contribute to the local economy by creating employment opportunities, supporting local communities, and improving supply chain efficiency once it comes into operation.
The company stated that the project reflects its commitment to local production, operational excellence, environmental responsibility, and community engagement. It also emphasised that the facility will maintain high standards in product quality, safety, and environmental stewardship.
Rohto Pharmaceutical Co., Ltd., the parent company of RMN, is a Japan-based multinational healthcare and skincare company with more than 125 years of history in pharmaceuticals and consumer healthcare.
Established in Nepal in 2019, Rohto Mentholatum Nepal produces skincare products under brands including Acnes, Sunplay, Selsun, Hada Labo, and Oxy.
